OTC : CDIX

Cardiff Lexington Corporation — News

$0.745 USD

-$0.15 (-17.22%)

Volume
24.8K
Average Volume
1.58K
Market Capitalization
$5.16M
P/E Ratio
-0.69
Dividend Yield
0.00%
Price Target
Year High
$14.25
Year Low
$0.40
Day High
Day Low
Payout Ratio
-$0.03
Current Ratio
$0.98
Source Headline
Cardiff Lexington Announces the Addition of Southeastern Surgery Center in Tallahassee, Florida to Nova Ortho and Spine Network

- Adds high visibility metropolitan location with potential for high patient volume - - 12th surgical center as company executes strategy to expand network throughout southeast and mid-Atlantic region - LEXINGTON, KY / ACCESS Newswire / June 29, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) ("Cardiff Lexington" or the "Company"), a healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that its Nova Ortho and Spine subsidiary has added Southeastern Surgery Center in Tallahassee, Florida to its growing network of surgical facilities, enhancing access to advanced orthopedic and spine care for patients in this region. Southeastern Surgery Center has earned a strong reputation over many years of operation, recognized for its commitment to exceptional patient care, outstanding patient satisfaction, and stringent patient safety standards.

accessnewswire.com - 2026-06-29 08:00:00

Cardiff Lexington's Nova Ortho and Spine Announces New Medical Office in Stuart, Florida to Serve the Growing Treasure Coast Community

LEXINGTON, KY / ACCESS Newswire / May 20, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) ("Cardiff Lexington" or the "Company"), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that Nova Ortho and Spine, a wholly owned subsidiary of Cardiff Lexington Corporation, has opened a new location in Stuart, Florida. This new location further strengthens Nova Ortho and Spine's expanding regional network of healthcare facilities throughout Florida and supports the organization's broader strategy of increasing accessibility to specialized orthopedic and spine services in underserved and high-growth markets.

accessnewswire.com - 2026-05-20 08:00:00

Cardiff Lexington Announces First Quarter 2026 Financial Results

LEXINGTON, KY / ACCESS Newswire / May 19, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) today announced financial results for the first quarter ended March 31, 2026. Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "We continue to strengthen and expand our network of Nova Ortho and Spine locations to support growing patient demand with a focus on more high value procedures, and we remain confident in our ability to build a scalable platform through organic growth and acquisitions that deliver exceptional outcomes for patients.

accessnewswire.com - 2026-05-19 08:00:00

Cardiff Lexington to Report First Quarter 2026 Financial Results and Host Conference Call on Tuesday, May 19, 2026

LEXINGTON, KY / ACCESS Newswire / May 14, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that the Company will host an investor conference call to discuss its financial and operating results for the first quarter ended March 31, 2026, on Tuesday, May 19, 2026, at 11:00 am ET. The Company will release its financial and operating results for the first quarter ended March 31, 2026, prior to the call on Tuesday, May 19, 2026.

accessnewswire.com - 2026-05-14 08:30:00

Get CDIX Insider Trade Alerts

CDIX Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

CDIX Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade